Found: 9
Select item for more details and to access through your institution.
Should anticancer drug doses be adjusted in the obese patient?
- Published in:
- 1995
- By:
- Publication type:
- Editorial
Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and Pharmacodynamics.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 2, p. 124
- By:
- Publication type:
- Article
Clinical and Pharmacologic Reappraisal of Dichloromethotrexate.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 19, p. 1547
- By:
- Publication type:
- Article
Clinical Pharmacology of Oral and Iv N-Methylformamide: A Pharmacologic Basis for Lack of Clinical Antineoplastic Activity2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 9, p. 671
- By:
- Publication type:
- Article
Pharmacology of Bone Marrow Transplantation Conditioning Regimensa.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 770, n. 1, p. 237, doi. 10.1111/j.1749-6632.1995.tb31059.x
- By:
- Publication type:
- Article
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Factors Affecting Topotecan Sensitivity in Human Leukemia Samples<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 128, doi. 10.1111/j.1749-6632.1996.tb26382.x
- By:
- Publication type:
- Article
Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 48, n. 4, p. 269, doi. 10.1007/s002800100330
- By:
- Publication type:
- Article